Page last updated: 2024-08-23

azides and 3-azidopyrimethamine

azides has been researched along with 3-azidopyrimethamine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baker, ND; Griffin, RJ; Irwin, WJ; Reichert, U; Schmidt, R1
Blackledge, G; Fuchs, R; Keizer, HJ; Kerbrat, P; Rankin, E; Somers, R; Sylvester, R; Thomas, D; van Oosterom, A; Verweij, J1
Blackledge, GR; Crawford, SM; Hoffman, R; Newlands, ES; Slack, J; Stevens, MF; Stuart, NS1
Gescher, A; Kamali, F; Slack, JA1
Baker, DC; Hand, ES; Haugwitz, RD; Narayanan, VL; Plowman, J; Rampal, JB; Safavy, A1

Other Studies

5 other study(ies) available for azides and 3-azidopyrimethamine

ArticleYear
Uptake, cytotoxicity and metabolism of m-azidopyrimethamine and related lipophilic antifolates in SV-K14 human keratinocytes in vivo.
    Biochemical pharmacology, 1991, Dec-11, Volume: 42 Suppl

    Topics: Animals; Anthralin; Azides; Cell Division; Cell Line, Transformed; Cell Survival; Culture Media; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Folic Acid Antagonists; Humans; In Vitro Techniques; Keratinocytes; Liver; Methotrexate; Mice; Mice, Hairless; Pyrimethamine; Regression Analysis; Skin

1991
A phase II study of M-azido-pyrimethamine ethane sulphonate (MZPES) in advanced, recurrent soft tissue sarcoma. An EORTC Soft Tissue and Bone Sarcoma Group Study.
    European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:12

    Topics: Adult; Aged; Azides; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Pyrimethamine; Sarcoma; Soft Tissue Neoplasms

1989
A phase I study of meta-azidopyrimethamine ethanesulphonate (MZPES)--a new dihydrofolate reductase inhibitor.
    Cancer chemotherapy and pharmacology, 1989, Volume: 23, Issue:5

    Topics: Antineoplastic Agents; Azides; Dose-Response Relationship, Drug; Drug Evaluation; Folic Acid Antagonists; Humans; Infusions, Intravenous; Neoplasms; Pyrimethamine; Pyrimidines

1989
Medicinal azides. Part 3. The metabolism of the investigational antitumour agent meta-azidopyrimethamine in mouse tissue in vitro.
    Xenobiotica; the fate of foreign compounds in biological systems, 1988, Volume: 18, Issue:10

    Topics: Animals; Antineoplastic Agents; Azides; Kidney; Liver; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Pyrimethamine; Pyrimidines; Subcellular Fractions

1988
Synthesis, chemical stability and pre-clinical anti-tumor activity of pyrazine diazohydroxide, sodium salt (NSC-361456).
    Anti-cancer drug design, 1987, Volume: 2, Issue:3

    Topics: Animals; Antineoplastic Agents; Azides; Drug Evaluation, Preclinical; Drug Stability; Female; Half-Life; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Pyrazines; Pyrimethamine; Pyrimidines

1987